Fulgent Genetics (FLGT) Non-Current Assets (2015 - 2026)

Fulgent Genetics (FLGT) has 12 years of Non-Current Assets data on file, last reported at $677.3 million in Q1 2026.

• Quarterly Non-Current Assets fell 14.15% year-over-year to $677.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 billion (down 16.99% YoY) and the FY2025 annual result came in at $663.0 million, down 23.47% from the prior year.
• Non-Current Assets rose to $677.3 million in Q1 2026 per FLGT's latest filing, from $663.0 million in the prior quarter.
• The five-year high for Non-Current Assets was $907.2 million in Q3 2024, with the low at -$534.6 million in Q4 2022.
• Average Non-Current Assets over 5 years is $698.7 million, with a median of $786.5 million recorded in 2022.
• Year-over-year, Non-Current Assets sank 180.18% in 2022 and soared 236.07% in 2023.
• Fulgent Genetics' Non-Current Assets stood at -$534.6 million in 2022, then soared by 236.07% to $727.5 million in 2023, then gained by 19.09% to $866.4 million in 2024, then slipped by 23.47% to $663.0 million in 2025, then rose by 2.16% to $677.3 million in 2026.
• Business Quant data shows FLGT's Non-Current Assets at $677.3 million in Q1 2026, $663.0 million in Q4 2025, and $707.2 million in Q3 2025.